Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
13.16
+0.26 (2.02%)
At close: Oct 23, 2026, 4:00 PM EDT
13.05
-0.11 (-0.84%)
After-hours: Oct 23, 2026, 7:50 PM EDT
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $1.22 billion as of October 23, 2026. It is the 9,044th most valuable company in the world and the 2,100th biggest in the United States. Its market cap has increased by 253.66% in one year.
Market Cap
1.22B
Enterprise Value
1.13B
1-Year Change
253.66%
Global Rank
Country Rank
#2,100 United States
Category
ChartMarket Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $1.22B, an increase of 249.98%. That is a compound annual growth rate of 24.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 1.22B | 187.90% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
| Mar 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taysha Gene Therapies | 1.29B |
| Nektar Therapeutics | 1.27B |
| LB Pharmaceuticals | 1.25B |
| Rapport Therapeutics | 1.24B |
| GH Research | 1.24B |
| Verastem | 1.22B |
| Omeros | 1.20B |
| Kardigan | 1.20B |